Pathological characterization of Kank in renal cell carcinoma

Experimental and Molecular Pathology

Volumn 78, Issue 1, 2005, Pages 41-48

  Chandra Roy, Badal ^a   Aoyagi, Teiichiro ^b   Sarkar, Shubhashish ^a   Nomura, Kimie ^c   Kanda, Hiroaki ^c   Iwaya, Keiichi ^b   Tachibana, Masaaki ^b   Kiyama, Ryoiti ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

CDKN2A; Renal cell carcinoma; Tumor suppressor

Indexed keywords

KANK PROTEIN; MONOCLONAL ANTIBODY; PROTEIN P16; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; KANK PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADRENAL CELL; ADULT; AGED; ARTICLE; CELL CULTURE; COLON; CONTROLLED STUDY; CYTOPLASM; DUODENUM; EMBRYO; ESOPHAGUS; FEMALE; FLUORESCENCE; GENE EXPRESSION; GLIA CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE CELL; LIVER CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CELL; PROSTATE; STOMACH; SUBMANDIBULAR GLAND; TESTIS CELL; THYROID CELL; UTERUS; WESTERN BLOTTING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; KIDNEY TUBULE; KIDNEY TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; KIDNEY TUBULES; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 16644376094     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2004.08.012     Document Type: Article

References (36)

1. H.X. An, A. Claas, L. Savelyeva, S. Seitz, P. Schlag, S. Scherneck, and M. Schwab Two regions of deletion in 9p23-24 in sporadic breast cancer Cancer Res. 59 1999 3941 3943
2. T. Aoyagi, K. Takishima, M. Hayakawa, and H. Nakamura Gene expression of TGF-alpha, EGF and IL-6 in cultured renal tubular cells and renal cell carcinoma Int. J. Urol. 3 1996 392 396
3. H. Bissig, J. Richter, R. Desper, V. Meier, P. Schraml, A.A. Schaffer, G. Sauter, M.J. Mihatsch, and H. Moch Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization Am. J. Pathol. 155 1999 267 274
4. P. Cairns, K. Tokino, Y. Eby, and D. Sidransky Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas Cancer Res. 55 1995 224 227
5. J. Cheng, D. Zhang, C. Zhou, and W.A. Marasco Down-regulation of HP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells Leuk. Res. 28 2004 71 82
6. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
7. D.T. Chui, D. Hammond, M. Baird, L. Shield, R. Jackson, and R.F. Jarrett Classical Hodgkin lymphoma is associated with frequent gains of 17q Genes Chromosomes Cancer 38 2003 126 136
8. N.N. Danial, J.A. Losman, T. Lu, N. Yip, K. Krishnan, J. Krolewski, S.P. Goff, J.Y. Wang, and P.B. Rothman Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation Mol. Cell. Biol. 18 1998 6795 6804
9. M. Giollant, S. Bertrand, P. Verrelle, A. Tchirkov, S. du Manoir, T. Ried, F. Mornex, J.F. Dore, T. Cremer, and P. Malet Characterization of double minute chromosomes' DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization Hum. Genet. 98 1996 265 270
10. B. Gunawan, W. Huber, M. Holtrup, A. von Heydebreck, T. Efferth, A. Poustka, R.H. Ringert, G. Jakse, and L. Fuzesi Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis Cancer Res. 61 2001 7731 7738
11. B. Gunawan, A. von Heydebreck, T. Fritsch, W. Huber, R.H. Ringert, G. Jakse, and L. Fuzesi Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors Cancer Res. 63 2003 6200 6205
12. N. Hatano, N.S. Nishikawa, C. McElgunn, S. Sarkar, K. Ozawa, Y. Shibanaka, M. Nakajima, K. Gohji, and R. Kiyama A comprehensive analysis of loss of heterozygosity caused by hemizygous deletions in renal cell carcinoma using a subtraction library Mol. Carcinog. 31 2001 161 170
13. F. Heinze, and G. Kovacs Identifying BAC clones for diagnosis of conventional renal cell carcinoma by FISH Histopathology 41 2002 308 312
14. M. Heyman, D. Grander, K. Brondum-Nielsen, Y. Liu, S. Soderhall, and S. Einhorn Deletions of the short arm of chromosome 9, including the interferon-alpha/-beta genes, in acute lymphocytic leukemia. Studies on loss of heterozygosity, parental origin of deleted genes and prognosis Int. J. Cancer 54 1993 748 753
15. S. Joos, M. Granzow, H. Holtgreve-Grez, R. Siebert, L. Harder, J.I. Martin-Subero, J. Wolf, M. Adamowicz, T.F. Barth, P. Lichter, and A. Jauch Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2 Int. J. Cancer 103 2003 489 495
16. V. Lacronique, A. Boureux, V.D. Valle, H. Poirel, C.T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O.A. Bernard A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 278 1997 1309 1312
17. R.Y. Liu, C. Fan, R. Garcia, R. Jove, and K.S. Zuckerman Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines Blood 93 2 1999 2369 2379
18. J. Lukas, D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 1995 503 506
19. H. Miyake, H. Nakamura, I. Hara, K. Gohji, S. Arakawa, S. Kamidono, and H. Saya Multifocal renal cell carcinoma: evidence for a common clonal origin Clin. Cancer Res. 4 1998 2491 2494
20. T. Nagase, N. Seki, K. Ishikawa, A. Tanaka, and N. Nomura Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1 DNA Res. 3 1996 17 24
21. C.A. Nunez, T.F. Zipf, W.M. Roberts, L.J. Medeiros, K. Hayes, and C.E. Bueso-Ramos Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia Arch. Pathol. Lab. Med. 127 2003 601 605
22. R. Ohki, M. Oishi, and R. Kiyama A whole-genome analysis of allelic changes in renal cell carcinoma by in-gel competitive reassociation Mol. Carcinog. 22 1998 158 166
23. P. Peeters, S.D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, P. Philip, F. Monpoux, L. Van Rompaey, M. Baens, H. Van den Berghe, and P. Marynen Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 90 1997 2535 2540
24. J.L. Phillips, B.M. Ghadimi, D. Wangsa, H. Padilla-Nash, R. Worrell, S. Hewitt, M. Walther, W.M. Linehan, R.D. Klausner, and T. Ried Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease Genes Chromosomes Cancer 31 2001 1 9
25. P. Rodley, N. Hatano, N.S. Nishikawa, B.C. Roy, S. Sarkar, and R. Kiyama A differential genomic cloning for cancer study: an outline and applications Recent Res. Devel. Mol. Biol. 1 2003 13 27
26. J.C. Presti Jr., M. Wilhelm, V. Reuter, P. Russo, R. Motzer, and F. Waldman Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney J. Urol. 167 2002 1464 1468
27. B.A. Rybicki, A.T. Savera, J.A. Gomez, S.C. Patel, N.E. Ballard, M.S. Benninger, R.J. Zarbo, and D.L. Van Dyke Allelic loss and tumor pathology in head and neck squamous cell carcinoma Mod. Pathol. 16 2003 970 979
28. M.E. Sanders, R. Mick, J.E. Tomaszewski, and F.G. Barr Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma Am. J. Pathol. 161 2002 997 1005
29. S. Sarkar, B.C. Roy, N. Hatano, T. Aoyagi, K. Gohji, and R. Kiyama A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma J. Biol. Chem. 277 2002 36585 36591
30. P. Schraml, D. Muller, R. Bednar, T. Gasser, G. Sauter, M.J. Mihatsch, and H. Moch Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma J. Pathol. 190 2000 457 461
31. P. Schraml, K. Struckmann, R. Bednar, W. Fu, T. Gasser, K. Wilber, J. Kononen, G. Sauter, M.J. Mihatsch, and H. Moch CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A Am. J. Pathol. 158 2001 593 601
32. J. Shao, Y. Li, H. Li, Q. Wu, J. Hou, and C. Liew Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas Chin. Med. J. (Engl) 113 2000 817 822
33. S.R. Shi, M.E. Key, and K.L. Kalra Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections J. Histochem. Cytochem. 39 1991 741 748
34. R. Simon, H. Burger, A. Semjonow, L. Hertle, H.J. Terpe, and W. Bocker Patterns of chromosomal imbalances in muscle invasive bladder cancer Int. J. Oncol. 17 2000 1025 1029
35. K. Spiekermann, S. Biethahn, S. Wilde, W. Hiddemann, and F. Alves Constitutive activation of STAT transcription factors in acute myelogenous leukemia Eur. J. Haematol. 67 2001 63 71
36. T. Taguchi, G.Z. Cheng, D.W. Bell, B. Balsara, Z. Liu, J.M. Siegfried, and J.R. Testa Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line Genes Chromosomes Cancer 20 1997 208 212